PRECIGEN, INC. — Investor Relations & Filings
Filings indexed
1,160
across all filing types
Latest filing
2026-04-30
Annual Report
Country
US
United States of America
Listing
US
PGEN
Precigen, Inc. is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing next-generation gene and cell therapies. The company utilizes precision technology to create highly targeted medicines for difficult-to-treat diseases. Its primary therapeutic areas of focus include immuno-oncology and autoimmune disorders. Precigen aims to provide innovative treatments for patients with significant unmet medical needs by advancing its portfolio of precision medicines.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - PRECIGEN, INC. (0001356090) (Filer) | 2026-04-30 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | |
| 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 39209630 | ARS - PRECIGEN, INC. (0001356090) (Filer) | 2026-04-30 | English | ||
| 33003256 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003253 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003251 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003245 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 33003240 | 4 - PRECIGEN, INC. (0001356090) (Issuer) | 2026-03-21 | English | ||
| 29056442 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 29056636 | SCHEDULE 13G Filing | 2026-01-23 | English | ||
|
2025
7 filings
| |||||
| 11953822 | PRIMARY DOCUMENT | 2025-12-23 | English | ||
| 11953825 | Regulatory Filings 2025 | 2025-12-23 | English | ||
| 11953823 | FORM 4 | 2025-12-16 | English | ||
| 11953826 | Regulatory Filings 2025 | 2025-12-13 | English | ||
| 11953828 | Major Shareholding Notification 2025 | 2025-11-22 | English | ||
| 11953827 | PRIMARY DOCUMENT | 2025-11-22 | English | ||
| 11953829 | Regulatory Filings 2025 | 2025-11-20 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
PRECIGEN, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32044/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32044 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32044 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32044 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32044}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PRECIGEN, INC. (id: 32044)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.